Adlai Nortye Group Ltd. American Depositary Shares (N2U0)
FSX
Real-time Data
06:00 AM
Day's Range
12.5052 wk Range
0.9100Overview - N2U0 - Adlai Nortye Group Ltd. American Depositary Shares
Key Statistics
Valuation
Enterprise Value
521.23M
Price / Sales (TTM)
‪43.86‬
Price / Book
‪4.30‬
EV / EBITDA
‪-27.95‬
Profitability
Profit Margin
‪-124.77%‬
Operating Margin
‪-44.18%‬
Return on Assets
‪-8.69%‬
Return on Equity
‪-20.22%‬
Ownership
Shares Outstanding
193.19M
Float
44.79M
Held by Insiders
‪0.57%‬
Held by Institutions
‪45.19%‬
Price stats
Beta
‪1.10‬
50-Day Avg
‪10.13‬
200-Day Avg
‪7.54‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - N2U0 - Adlai Nortye Group Ltd. American Depositary Shares
Peers - N2U0 - Adlai Nortye Group Ltd. American Depositary Shares
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- N2U0FSXAdlai Nortye Ltd. ADR792.09MMarket Cap+88.13%52-week change—P/E (Trailing)‪-124.77%‬Profit Margin
- ANLFSXAnalog Devices Inc.151.88BMarket Cap+35.24%52-week change43.41P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE52.93BMarket Cap+23.73%52-week change38.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt51.30BMarket Cap+24.85%52-week change36.06P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna Inc.50.90BMarket Cap+83.96%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.38.16BMarket Cap+25.45%52-week change136.57P/E (Trailing)‪30.74%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.64BMarket Cap+77.80%52-week change-29.52P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - N2U0 - Adlai Nortye Group Ltd. American Depositary Shares
About
Adlai Nortye Ltd. ADR is the American Depositary Receipt representing shares of Adlai Nortye Ltd., a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative cancer therapies. The company leverages its dual R&D presence in the United States and China to advance a robust…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
